Edition:
United Kingdom

Neuca SA (NEUP.WA)

NEUP.WA on Warsaw Stock Exchange

233.00PLN
14 Nov 2018
Change (% chg)

-2.00zł (-0.85%)
Prev Close
235.00zł
Open
230.00zł
Day's High
235.00zł
Day's Low
230.00zł
Volume
11
Avg. Vol
3,337
52-wk High
316.50zł
52-wk Low
221.00zł

Chart for

About

Neuca SA is a Poland-based company engaged in the healthcare sector. The Company’s main activities comprise the wholesale of pharmaceuticals; running its own pharmacies under the brand name Synoptis Pharma; provision of advertising, marketing and information technology (IT) services to healthcare market, production of pharmaceut... (more)

Overall

Beta: 0.16
Market Cap(Mil.): zł1,264.09
Shares Outstanding(Mil.): 4.68
Dividend: 5.75
Yield (%): 2.13

Financials

  NEUP.WA Industry Sector
P/E (TTM): 14.02 21.57 40.64
EPS (TTM): 19.28 -- --
ROI: 15.06 11.87 61.69
ROE: 17.17 13.83 73.21

BRIEF-Neuca Offers To Buy Back 150,000 Of Own Shares

* OFFERS TO BUY BACK NO MORE THAN 150,000 OF CO'S SHARES REPRESENTING 3.24 PCT OF ITS SHARE CAPITAL FOR 235 ZLOTYS/SHARE

13 Nov 2018

BRIEF-Neuca Q3 Net Profit Up At 24.1 Mln Zlotys

* REPORTS Q3 NET PROFIT OF 24.1 MLN ZLOTYS VS 21.7 MLN ZLOTYS YEAR AGO

12 Nov 2018

BRIEF-Neuca Q2 Net Profit Rises To 18.5 Mln Zlotys

Aug 29 NEUCA SA: * Q2 NET PROFIT 18.5 MLN ZLOTYS VS 11.8 MLN ZLOTYS YEAR AGO * Q2 REVENUE 1.78 BLN ZLOTYS VS 1.78 BLN ZLOTYS YEAR AGO * Q2 OPER PROFIT 24.8 MLN ZLOTYS VS 16.1 MLN ZLOTYS YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

29 Aug 2018

Earnings vs. Estimates